Vimarsana
Biggest News Aggregation in the World

Page 4 - Lin Chang News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Lin Chang. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Lin Chang Today - Breaking & Trending Today

fodmap: Want to get rid of bowel problems? Follow the low-FODMAP diet - Vimarsana News

fodmap: Want to get rid of bowel problems? Follow the low-FODMAP diet

FODMAPs are certain types of carbohydrates - called fermentable oligosaccharides, disaccharides, monosaccharides and polyols, as the acronym suggests - that often can't be fully digested or absorbed in the small intestine and are instead fermented by microbes in the colon. This can cause gastrointestinal distress.

UCLA in the News June 29, 2023 - Vimarsana News

UCLA in the News June 29, 2023

Highlights from the Associated Press, Time, BBC News and others.

Source: ucla.edu
Gastroenterology Guidelines Suggest 2 New Treatments for Chronic Constipation - Vimarsana News

Gastroenterology Guidelines Suggest 2 New Treatments for Chronic Constipation

The American Gastroenterological Association and the American College of Gastroenterology announced new guidelines for treating chronic idiopathic constipation. Magnesium oxide and senna-based laxatives are among the 10 evidence-based methods for treating constipation noted in the updated guidelines.

Source: health.com
New Chronic Constipation Guideline Weighs Treatment Options - Vimarsana News

New Chronic Constipation Guideline Weighs Treatment Options

Evidence for a range of prescription and over-the-counter therapies, along with specific recommendations for implementing them, are laid out in a joint AGA-ACG guideline.

Guidelines Developed for Treating Chronic Idiopathic Constipation - Vimarsana News

Guidelines Developed for Treating Chronic Idiopathic Constipation

Strong recommendations made for use of polyethylene glycol, sodium picosulfate, linaclotide, plecanatide, and prucalopride.

Source: empr.com